Human papillomavirus (HPV) is an important causative agent of cervical carcinoma and some malignant cutaneous tumors. The integration of HPV DNA into the host genome is one of the most important risk factors for malignant transformation. Here, we report the case of a 53-year-old man with multiple, black-brown genital macules and nodules. Histological findings resembled those for Bowen's disease, and we made a diagnosis of bowenoid papulosis. This condition is generally benign, but invasive squamous cell carcinoma (SCC) arising from bowenoid papulosis has been previously reported. Therefore, we took biopsy specimens from 10 lesions and tested them for the presence of HPV DNA. DNA sequencing identified HPV type 16 (HPV-16) DNA in all samples. Next, we excised 4 different relatively large lesions and performed an amplification of papillomavirus oncogene transcripts (APOT) assay. This assay showed that all samples had only episome-derived viral transcripts, indicating no integration of HPV DNA into the host genome. We have followed this case for 3 years, and no progression to Bowen's disease or SCC has so far been observed. We conclude that the APOT assay is a feasible method for evaluating the malignant potential of bowenoid papulosis.
Introduction
Human papillomavirus (HPV) infection of the genital skin shows a variety of presentations ranging from benign condyloma acuminata to squamous cell carcinoma (SCC) [1, 2] . Bowenoid papulosis is a condition that histologically resembles Bowen's disease and manifests small verrucous papules and nodules on the genitalia [3] . The condition is benign and has a tendency towards spontaneous resolution. The high-risk, oncogenic HPV type 16 (HPV-16) has been detected in most cases, and invasive SCC arising from bowenoid papulosis has been described in some cases [4] . Here we report the case of a 53-year-old man with bowenoid papulosis in which the amplification of papillomavirus oncogene transcripts (APOT) assay served as a feasible method for evaluating prognosis.
Materials and Methods

Patient
A 53-year-old man presented with multiple skin lesions on the genital area. The lesions were first noticed 3 years earlier. His medical history included diabetes mellitus for 3 years and hypertension for 5 years. His family history was unremarkable. Physical examination revealed multiple, keratotic, black-brown macules and nodules 0.5 -3.0 cm in diameter on his genitalia (Figure 1) . Inguinal lymph nodes were not palpable. Skin biopsies were taken from 2 lesions, including both nodule and plaque. Histological findings from the nodule and plaque showed a variable extent of hyperkeratosis, irregular acanthosis, papillomatosis, and cytological atypia with few dyskeratotic cells in the entire upper epidermis (Figure 2 ). embedded in paraffin. The sections were routinely passed through xylene and a graded alcohol series, and stained with several antibodies using the avidin-biotin-peroxidase complex method. Peroxidase binding was detected using the diaminobenzidine method, and the sections were then lightly counterstained with hematoxylin for microscopic examination.
Immunohistochemical Study
HPV Typing and APOT Assay
Total DNA was extracted from the lesions and HPV DNA was amplified using GP5/GP6 primers. The amplification products were sequenced using an ABI 3100 sequencer.
Total RNA was isolated and reverse transcribed using a commercial kit (Superscript III First-Strand Synthesis System; Invitrogen Corp., Carlsbad, CA, USA) and an oligo-(dT) 17 primer coupled to a linker sequence. PCR amplification for the APOT assay was carried out as previously described [5, 6] . APOT products were visualized by performing agarose gel electrophoresis, excised from the gel, and sequenced using an ABI 3100 sequencer. G3PDH transcript was used as control.
Results
Histologic Detection of HPV
First, we performed an immunohistochemical analysis using the anti-HPV capsid antigen antibody, K1H8 (DAKO, Tokyo, Japan). The analysis indicated that some epidermal keratinocytes were HPV-positive (data not shown). After confirmation of HPV infection, we proceeded to further HPV analysis.
Identification of HPV-16
Next, we extracted total DNA from biopsy specimens taken from 10 pigmented lesions. We performed PCR amplification using GP5/GP6 primers targeting the HPV L1 gene and sequenced the PCR products. After alignment of our sequences with HPV L1 sequences obtained in GenBank, conserved sequence regions were selected and analyzed using a computer software program. We identified sequences corresponding with HPV-16 in all 10 samples.
APOT Assay Detected Only Episome-Derived Viral Transcripts
To know the extent of the integration of HPV into the patient's genome, we performed an APOT assay [5] [6] [7] . We excised 4, relatively large different lesions. Total RNA was isolated and reverse transcribed. APOT products were visualized by agarose gel electrophoresis. The result was shown in Figure 3 . PCR amplification detected the bands corresponding to the episomal form of HPV-16 transcript in samples 1, 2 and 4 while sample 3 showed no clear band. Also we found an additional short band in sample 4, the size of which was predicted to be integrated form. Sequence analysis of those bands revealed that all larger band (black arrow in Figure) had only episome-derived viral transcripts and the smaller band (white arrow in Figure 3 ) was also originated from the viral transcript, indicating no integration of the HPV DNA into the host genome (Figure 3) . Host DNA could not be found by sequence analysis. We have followed this case for 3 years and so far have observed no progression to Bowen's disease or SCC.
Discussion
Our patient showed multiple pigmented genital macules and nodules, and our clinical diagnosis was bowenoid papulosis. Histological findings were compatible to those for Bowen's disease and indicated bowenoid papulosis.
HPV is an etiological agent in cervical carcinomas and causes various types of malignant and benign skin tumors, including SCC, Bowen's disease, and bowenoid papulosis [1] [2] [3] . Bowenoid papulosis is benign, although HPV-16 has been detected in most cases. In our case, we took DNA from 10 lesions and detected HPV-16 in all samples. However, SCC arising from a bowenoid papulosis has been described in some cases [4] . Persistent infection with high-risk HPV types, such as HPV-16, 18, 31, 33, and 45, is necessary but insufficient for cervical carcinoma development. Integration of the HPV DNA into the host genome is one of the most important risk factors for malignant transformation [8] . The APOT assay can detect transcriptionally active virus-host fusion transcripts and distinguish between episomal and integrated HPV DNA [6] . In addition, the assay can determine the precise integration site of the viral genome in host chromosomes. The APOT assay requires only a small tissue sample and allows for the analysis of integration sites in multiple locations on the lesion.
Recently, we reported the case of a patient with multiple black plaques and an erythematous nodule on the vulva [7] . On histological examination, multifocal vulvar Bowen's disease and invasive SCC were found. APOT assay showed that 2 locations of Bowen's disease had only episome-derived HPV-16 transcripts, but another 2 sites of Bowen's disease and the nodule of invasive SCC had HPV-16 transcripts derived from integration.
We therefore performed an APOT assay about sample form 4 lesions in the present case. The result showed that samples 1 and 2 showed only the bands from episomederived HPV-16 transcripts. No band was observed in the lane of sample 3, but we did not know the reason. Also sample 4 showed the larger and smaller bands. The former band was corresponding to that from the episomal form. The smaller band was thought to be the band from the integrated form, but sequence analysis could detect only HPV-16 transcript without host sequence. We concluded that there was no integration of viral genome to host genome in this case. In fact, a 3-year follow-up did not show transformation to SCC. We suggest that the APOT assay is a feasible method for evaluating the clinical degree of malignancy in bowenoid papulosis.
